Comments
Loading...
Polyrizon (PLRZ) Forecast
NewsEarningsPolyrizon (PLRZ) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPolyrizon (NASDAQ:PLRZ) Stock Quotes, Forecast and News Summary
Polyrizon Stock (NASDAQ: PLRZ) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Polyrizon (PLRZ) stock?
You can purchase shares of Polyrizon (NASDAQ:PLRZ) through any online brokerage.
Who are Polyrizon (PLRZ) competitors?
Other companies in Polyrizon’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Synaptogenix (NASDAQ:SNPX), Evaxion Biotech (NASDAQ:EVAX), TransCode Therapeutics (NASDAQ:RNAZ) and Protagenic Therapeutics (NASDAQ:PTIX).
What is the forecast, or price target, for Polyrizon (PLRZ) stock?
There is no analysis for Polyrizon to provide a consensus price target.
What is the current price for Polyrizon (PLRZ)?
The stock price for Polyrizon (NASDAQ: PLRZ) is $3.18 last updated December 18, 2024 at 11:31 AM EST.
Does Polyrizon (PLRZ) pay a dividend?
There are no upcoming dividends for Polyrizon.
When is Polyrizon (NASDAQ:PLRZ) reporting earnings?
Polyrizon’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is Polyrizon (PLRZ) going to split?
There is no upcoming split for Polyrizon.
What sector and industry does Polyrizon (PLRZ) operate in?
Polyrizon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.